BDNF and major depressive disorder: Our data are not in line with our previous pilot study, in which we had found that all MDD patients—not only the severely depressed ones—who showed a hypomethylation at the CpG-87 site of the exon IV promoter region of the BDNF gene were less likely to benefit from the therapy with antidepressants (11).